EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Missing the mark? Exploratory analysis of the 10‐year‐old cutoff as an independent marker of high‐risk disease in pediatric B‐ALL

Paul E George, Nicholas P DeGroote, Michaela Henderson, Katherine Jordan, Christiana Ziworitin-Ogola, Sharon M Castellino, Tamara P Miller iD

Pediatric Blood & Cancer · 2024

DOI: 10.1002/pbc.30825 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Paul E George und 6 weiteren Autor:innen. Beteiligte Einrichtung: Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This single‐center, retrospective study evaluated age as a risk factor for relapsed/refractory disease and/or death in 153 children with B‐cell acute lymphoblastic leukemia. The study sample included children near the 10‐year age cutoff for high‐risk disease (6.0‐13.9 years at diagnosis) and without other high‐risk features (high white cell count, unfavorable cytogenetics). Children 10.0‐13.9 years treated per high‐risk protocols did not have inferior outcomes compared with children aged 6.0‐9.9 years initiating treatment per standard‐risk protocols. The study indicates that, in the era of cytogenetics, an age threshold of 10 years might not be an independent prognostic marker. Multicenter analyses are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor Cell Lymphoblastic Leukemia-LymphomaPrecursor B-Cell Lymphoblastic Leukemia-LymphomaChildHumansRetrospective StudiesRisk FactorsPrognosisAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

AgeB-cell acute lymphoblastic leukemiaoutcomespediatric

Autor:innen und Institutionen

  • Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Health Policy and Management, Emory University Rollins School of Public Health, Atlanta, Georgia, USA.

ORCID-Profile: Tamara P Miller

Förderung

  • NCI NIH HHS

Zitieren

APA

George, P. E., DeGroote, N. P., Henderson, M., Jordan, K., Ziworitin-Ogola, C., Castellino, S. M., & Miller, T. P. (2024). Missing the mark? Exploratory analysis of the 10‐year‐old cutoff as an independent marker of high‐risk disease in pediatric B‐ALL. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30825

Vancouver

George PE, DeGroote NP, Henderson M, Jordan K, Ziworitin-Ogola C, Castellino SM, et al. Missing the mark? Exploratory analysis of the 10‐year‐old cutoff as an independent marker of high‐risk disease in pediatric B‐ALL. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.30825

BibTeX
@article{George2024,
  author = {George, Paul E and DeGroote, Nicholas P and Henderson, Michaela and Jordan, Katherine and Ziworitin-Ogola, Christiana and Castellino, Sharon M and Miller, Tamara P},
  title = {Missing the mark? Exploratory analysis of the 10‐year‐old cutoff as an independent marker of high‐risk disease in pediatric B‐ALL},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  doi = {10.1002/pbc.30825}
}
Kostenlos starten →